ALMS ALUMIS INC.
Nasdaq · SEC CIK 1847367 · EDGAR
- Bought, last 12 months
- $61.68M 17 purchases by 6 insiders
- Sold, last 12 months
- $1.55M 8 sales by 7 insiders
- Filings on record
- 88 since 2024-07-01, latest 2026-09-09 21:39
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| AKKARAJU SRINIVAS | Dir | $29.80M | $1.01M |
| Tananbaum James B. | Dir, 10% | $10.63M | — |
| Foresite Labs Fund I, L.P. | 10% | $7.53M | — |
| Foresite Labs, LLC | 10% | $7.00M | — |
| Foresite Labs Affiliates 2021, LLC | 10% | $3.63M | — |
| Foresite Capital Management VI LLC | 10% | $3.09M | — |
| Pangali Sanam | CLO | — | $176.0K |
| Schroer John R. | CFO | — | $86.5K |
| Hardiman Roy C. | Chief Business, Strategy Ofcr | — | $71.0K |
| Goldstein David M | CSO | — | $68.5K |
Transactions 79
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-09 21:39 | 2026-09-04+ | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $10.87 | +986.7K | 2.30M | +75% | +$10.73M |
| MI | 2026-09-09 21:39 | 2026-09-08 | ALMS | AKKARAJU SRINIVAS | Dir | S - Sale | $10.55 | -96.1K | 2.03M | -5% | -$1.01M |
| 2026-08-05 18:50 | 2026-08-03 | ALMS | Schroer John R. | CFO | S - Sale | $26.37 | -3,282 | 24.7K | -12% | -$86.5K | |
| 2026-08-05 18:46 | 2026-08-03 | ALMS | Pangali Sanam | CLO | S - Sale | $26.37 | -1,364 | 9,747 | -12% | -$36.0K | |
| 2026-08-05 18:44 | 2026-08-03 | ALMS | Hardiman Roy C. | Chief Business, Strategy Ofcr | S - Sale | $26.37 | -2,692 | 207.7K | -1% | -$71.0K | |
| 2026-08-05 18:40 | 2026-08-03 | ALMS | Goldstein David M | CSO | S - Sale | $26.37 | -2,596 | 31.0K | -8% | -$68.5K | |
| 2026-08-05 18:36 | 2026-08-03 | ALMS | Drappa Jorn | Chief Medical Off | S - Sale | $26.37 | -2,447 | 56.9K | -4% | -$64.5K | |
| 2026-08-05 18:21 | 2026-08-03 | ALMS | Bradley Mark Christopher | Chief Development Off | S - Sale | $26.37 | -2,572 | 48.5K | -5% | -$67.8K | |
| D | 2026-07-08 16:40 | 2026-07-06 | ALMS | Pangali Sanam | CLO | M - OptEx | $5.06 | +5,000 | 16.1K | +45% | +$25.3K |
| D | 2026-07-08 16:40 | 2026-07-06 | ALMS | Pangali Sanam | CLO | S - Sale+OE | $28.00 | -5,000 | 11.1K | -31% | -$140.0K |
| D | 2026-07-02 18:30 | 2026-06-30 | ALMS | TETRAULT LYNN A. | Dir | A - Grant | $0.00 | +3,553 | 3,553 | New | $0 |
| D | 2026-07-02 18:28 | 2026-06-30 | ALMS | Yao Zhengbin | Dir | A - Grant | $0.00 | +3,553 | 27.1K | +15% | $0 |
| D | 2026-07-02 18:26 | 2026-06-30 | ALMS | Srivastava Sapna | Dir | A - Grant | $0.00 | +3,553 | 3,553 | New | $0 |
| D | 2026-07-02 18:24 | 2026-06-30 | ALMS | Machado Patrick | Dir | A - Grant | $0.00 | +3,553 | 3,553 | New | $0 |
| D | 2026-07-02 18:22 | 2026-06-30 | ALMS | AKKARAJU SRINIVAS | Dir | A - Grant | $0.00 | +3,553 | 3,553 | New | $0 |
| DM | 2026-05-27 19:06 | 2026-05-22 | ALMS | Drappa Jorn | Chief Medical Off | M - OptEx | $6.65 | +26.9K | 59.3K | +83% | +$178.6K |
| MI | 2026-04-03 15:55 | 2026-04-01 | ALMS | Foresite Labs, LLC | 10% | J - Other | $0.00 | -496.0K | 680.5K | -42% | $0 |
| MI | 2026-04-03 15:54 | 2026-04-01 | ALMS | Foresite Capital Management VI LLC | 10% | J - Other | $0.00 | -496.0K | 680.5K | -42% | $0 |
| MI | 2026-04-03 15:53 | 2026-04-01 | ALMS | Tananbaum James B. | Dir, 10% | J - Other | $0.00 | -496.0K | 680.5K | -42% | $0 |
| I | 2026-01-13 | 2026-01-09 | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $17.00 | +588.2K | 1.85M | +46% | +$10.00M |
| MI | 2026-01-12 | 2026-01-08 | ALMS | Foresite Labs Fund I, L.P. | 10% | P - Purchase | $17.00 | +411.8K | 2.91M | +16% | +$7.00M |
| MI | 2026-01-12 | 2026-01-08 | ALMS | Tananbaum James B. | Dir, 10% | P - Purchase | $17.00 | +411.8K | 5.70M | +8% | +$7.00M |
| MI | 2026-01-12 | 2026-01-08 | ALMS | Foresite Labs, LLC | 10% | P - Purchase | $17.00 | +411.8K | 2.91M | +16% | +$7.00M |
| MI | 2025-12-09 | 2025-12-05 | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $9.84 | +186.4K | 1.14M | +19% | +$1.83M |
| MI | 2025-12-04 | 2025-12-02+ | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $7.79 | +262.0K | 912.8K | +40% | +$2.04M |
| MI | 2025-12-01 | 2025-11-26+ | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $7.55 | +173.6K | 691.8K | +33% | +$1.31M |
| I | 2025-11-25 | 2025-11-21 | ALMS | Tananbaum James B. | Dir, 10% | P - Purchase | $7.38 | +72.2K | 2.61M | +3% | +$532.9K |
| I | 2025-11-25 | 2025-11-21 | ALMS | Foresite Labs Affiliates 2021, LLC | 10% | P - Purchase | $7.38 | +72.2K | 2.61M | +3% | +$532.9K |
| I | 2025-11-25 | 2025-11-21 | ALMS | Foresite Labs Fund I, L.P. | 10% | P - Purchase | $7.38 | +72.2K | 2.61M | +3% | +$532.9K |
| I | 2025-11-24 | 2025-11-20 | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $7.20 | +125.7K | 643.3K | +24% | +$905.3K |
| MI | 2025-11-19 | 2025-11-17+ | ALMS | Foresite Capital Management VI LLC | 10% | P - Purchase | $6.09 | +507.9K | 2.54M | +25% | +$3.09M |
| MI | 2025-11-19 | 2025-11-17+ | ALMS | Tananbaum James B. | Dir, 10% | P - Purchase | $6.09 | +507.9K | 2.08M | +32% | +$3.09M |
| MI | 2025-11-19 | 2025-11-17+ | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $6.34 | +241.3K | 379.7K | +174% | +$1.53M |
| MI | 2025-11-19 | 2025-11-17+ | ALMS | Foresite Labs Affiliates 2021, LLC | 10% | P - Purchase | $6.09 | +507.9K | 2.23M | +29% | +$3.09M |
| I | 2025-11-17 | 2025-11-13 | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $5.25 | +276.2K | 276.2K | New | +$1.45M |
| D | 2025-07-31 | 2025-07-29 | ALMS | Goldstein David M | CSO | A - Grant | $0.00 | +27.0K | 29.1K | +1,277% | $0 |
| D | 2025-07-31 | 2025-07-29 | ALMS | Pangali Sanam | CLO | A - Grant | $0.00 | +10.0K | 11.1K | +900% | $0 |
| D | 2025-07-31 | 2025-07-29 | ALMS | Drappa Jorn | Chief Medical Off | A - Grant | $0.00 | +25.4K | 28.4K | +848% | $0 |
| D | 2025-07-31 | 2025-07-29 | ALMS | Bradley Mark Christopher | Chief Development Off | A - Grant | $0.00 | +26.8K | 48.7K | +122% | $0 |
| D | 2025-07-31 | 2025-07-29 | ALMS | Schroer John R. | CFO | A - Grant | $0.00 | +28.0K | 28.0K | New | $0 |
| D | 2025-07-31 | 2025-07-29 | ALMS | Richardson Derrick | SVP, People, Culture | A - Grant | $0.00 | +42.8K | 42.8K | New | $0 |
| D | 2025-07-31 | 2025-07-29 | ALMS | Hardiman Roy C. | Chief Business, Strategy Ofcr | A - Grant | $0.00 | +28.0K | 206.4K | +16% | $0 |
| DI | 2025-05-23 | 2025-05-21 | ALMS | Machado Patrick | Dir | A - Grant | — | +7,064 | 7,064 | New | — |
| I | 2025-05-23 | 2025-05-21 | ALMS | AKKARAJU SRINIVAS | Dir | A - Grant | — | +1.21M | 4.80M | +34% | — |
| I | 2025-05-23 | 2025-05-21 | ALMS | AyurMaya Capital Management Company, LP | Dir, 10%, See Remarks | A - Grant | — | +4.49M | 15.14M | +42% | — |
| MI | 2025-05-06 | 2025-05-02+ | ALMS | Tananbaum James B. | Dir, 10% | P - Purchase | $4.50 | +45.0K | 4.23M | +1% | +$202.3K |
| MI | 2025-05-06 | 2025-05-02+ | ALMS | Foresite Labs Management I, LLC | 10% | P - Purchase | $4.50 | +45.0K | 4.25M | +1% | +$202.3K |
| MI | 2025-05-06 | 2025-05-02+ | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $4.61 | +320.3K | 3.56M | +10% | +$1.48M |
| MI | 2025-05-06 | 2025-05-02+ | ALMS | Foresite Labs Affiliates 2021, LLC | 10% | P - Purchase | $4.50 | +45.0K | 4.23M | +1% | +$202.3K |
| MI | 2025-04-03 | 2025-04-01+ | ALMS | Colowick Alan | Dir | P - Purchase | $7.03 | +18.4K | 16.1K | New | +$129.5K |
| I | 2025-04-03 | 2025-04-01 | ALMS | Babler Martin | Pres, CEO, COB, Dir | P - Purchase | $6.44 | +15.7K | 106.5K | +17% | +$100.8K |
| AI | 2024-08-27 | 2024-07-01 | ALMS | AKKARAJU SRINIVAS | Dir | P - Purchase | $16.00 | +1.56M | 3.27M | +92% | +$25.00M |
| DMI | 2024-07-03 | 2024-07-01 | ALMS | Tananbaum James B. | Dir, 10% | C - Cnv Deriv | $0.00 | +11.48M | 4.25M | New | $0 |
| DMI | 2024-07-03 | 2024-07-01 | ALMS | Tananbaum James B. | Dir, 10% | P - Purchase | $16.00 | +2.50M | 4.20M | +147% | +$40.00M |
| DI | 2024-07-03 | 2024-07-01 | ALMS | GOEL DAVID E. | Dir, 10%, See Remarks | C - Cnv Deriv | — | +8.15M | 8.15M | New | — |
| DI | 2024-07-03 | 2024-07-01 | ALMS | GOEL DAVID E. | Dir, 10%, See Remarks | A - Grant | $16.00 | +2.50M | 10.65M | +31% | +$40.00M |
| DMI | 2024-07-03 | 2024-07-01 | ALMS | Foresite Capital Opportunity Management V, LLC | 10% | C - Cnv Deriv | $0.00 | +11.48M | 3.07M | New | $0 |
| DMI | 2024-07-03 | 2024-07-01 | ALMS | Foresite Capital Opportunity Management V, LLC | 10% | P - Purchase | $16.00 | +2.50M | 5.58M | +81% | +$40.00M |
| DMI | 2024-07-03 | 2024-07-01 | ALMS | Foresite Labs Affiliates 2021, LLC | 10% | C - Cnv Deriv | $0.00 | +11.48M | 967.6K | New | $0 |
| DMI | 2024-07-03 | 2024-07-01 | ALMS | Foresite Labs Affiliates 2021, LLC | 10% | P - Purchase | $16.00 | +2.50M | 5.58M | +81% | +$40.00M |
| DI | 2024-07-01 | 2024-07-01 | ALMS | Babler Martin | Pres, CEO, COB, Dir | A - Grant | — | +90.8K | 90.8K | New | — |
| DI | 2024-07-01 | 2024-07-01 | ALMS | Babler Martin | Pres, CEO, COB, Dir | D - Sale to Iss | — | -90.8K | 0 | -100% | — |
| DMI | 2024-07-01 | 2024-07-01 | ALMS | Goldstein David M | CSO | A - Grant | — | +216.9K | 213.9K | New | — |
| DMI | 2024-07-01 | 2024-07-01 | ALMS | Goldstein David M | CSO | D - Sale to Iss | — | -216.9K | 0 | -100% | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Yao Zhengbin | Dir | A - Grant | — | +23.5K | 23.5K | New | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Yao Zhengbin | Dir | D - Sale to Iss | — | -23.5K | 0 | -100% | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Klein Sara | GC - Corp Secy | D - Sale to Iss | — | -33.8K | 0 | -100% | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Klein Sara | GC - Corp Secy | A - Grant | — | +33.8K | 33.8K | New | — |
| DI | 2024-07-01 | 2024-07-01 | ALMS | AKKARAJU SRINIVAS | Dir | C - Cnv Deriv | — | +1.70M | 1.70M | New | — |
| DI | 2024-07-01 | 2024-07-01 | ALMS | AKKARAJU SRINIVAS | Dir | A - Grant | — | +1.70M | 1.70M | New | — |
| DI | 2024-07-01 | 2024-07-01 | ALMS | AKKARAJU SRINIVAS | Dir | D - Sale to Iss | — | -1.70M | 0 | -100% | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Bradley Mark Christopher | Chief Development Off | D - Sale to Iss | — | -22.0K | 0 | -100% | — |
| DMI | 2024-07-01 | 2024-07-01 | ALMS | Bradley Mark Christopher | Chief Development Off | D - Sale to Iss | — | -40.1K | 0 | -100% | — |
| DMI | 2024-07-01 | 2024-07-01 | ALMS | Bradley Mark Christopher | Chief Development Off | A - Grant | — | +40.1K | 20.0K | New | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Bradley Mark Christopher | Chief Development Off | A - Grant | — | +22.0K | 22.0K | New | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Hardiman Roy C. | Chief Business, Legal Off | D - Sale to Iss | — | -175.4K | 0 | -100% | — |
| DI | 2024-07-01 | 2024-07-01 | ALMS | Hardiman Roy C. | Chief Business, Legal Off | D - Sale to Iss | — | -6,417 | 0 | -100% | — |
| DI | 2024-07-01 | 2024-07-01 | ALMS | Hardiman Roy C. | Chief Business, Legal Off | A - Grant | — | +6,417 | 6,417 | New | — |
| D | 2024-07-01 | 2024-07-01 | ALMS | Hardiman Roy C. | Chief Business, Legal Off | A - Grant | — | +175.4K | 175.4K | New | — |
Purchase Sale Sale after option exercise All abbreviations